Human Papillomavirus Infection in a Male Population Attending a Sexually Transmitted Infection Service

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Álvarez Argüelles, Marta Elena ^a   Melón, Santiago ^a   Junquera, Maria Luisa ^b   Boga, Jose Antonio ^a   Villa, Laura ^a   Pérez Castro, Sonia ^c   de Oña, María ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL MONTE NARANCO   (Spain)

^c UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN E7;

ADOLESCENT; ADULT; AGE; AGED; ANUS INJURY; ARTICLE; CONDYLOMA; CONTROLLED STUDY; E6 GENE; E7 GENE; GENE AMPLIFICATION; GENOME ANALYSIS; GENOMIC FRAGMENT; GENOTYPE; HEALTH SERVICE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; PENIS INJURY; POLYMERASE CHAIN REACTION; PREVALENCE; URETHRA INJURY; VIRUS GENOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CAPSID PROTEINS; COINFECTION; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SPAIN;

HUMAN PAPILLOMAVIRUS;

EID: 84872844285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054375     Document Type: Article

References (47)

1. Georgieva S, Iordanov V, Sergieva S, (2009) Nature of cervical cancer and other HPV-associated cancers. J Buon 14 (3): 391-8.
2. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S, (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J Cancer 88: 63-73.
3. Walboomers J, Jacobs M, Manos M, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
4. Smith J, Lindsay L, Hoots B, Keys J, Franceschi S, et al. (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 21: 621-32.
5. Grulich AE, Jin F, Conway EL, Stein AN, Hocking J, (2010) Cancers attributable to human papillomavirus infection. Sex Health 7 (3): 244-52.
6. Miralles-Guri C, Bruni L, Cubilla AL, Castellsagué X, Bosch FX, et al. (2009) Human Papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 62 (10): 870-8.
7. Giuliano A, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, et al. (2008) Epidemiology of Human Papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26 (Suppl 10:): K17-28.
8. Ferenczy A, Coutlée F, Franco E, Hankins C, (2003) Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ 169 (5): 431-4 Review.
9. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, et al. (2012) Anal human papilomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 13 (5): 487-500.
10. Frich M, Smith E, Grulich A, Johansen C, (2003) Cancer in a population-based cohort of men and women in registered homosexual partnerships. Am J Epidemiol 157: 966-72.
11. Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, et al. (2010) Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the international Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 39: 166-81.
12. Weaver BA, Feng Q, Holmes KK, Kiviat N, Lee SK, et al. (2004) Evaluation of genital sites and sampling techniques for detection of human papilomavirus DNA in men. J Infect Dis 189 (4): 677-85.
13. Giuliano AR, Lu B, Nielson CM, Flores R, Papenfuss MR, et al. (2008) Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis 98 (6): 827-35.
14. Smith J, Baches D, Hudgens M, Bailey RC, Veronesi G, et al. (2010) Prevalence and risk factor of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer 126 (2): 572-7.
15. Barzon L, Militello V, Pagni S, Franchin E, Dal Bello F, et al. (2010) Distribution of human papillomavirus types in the anogenital tract of females and males. J Med Virol 82 (8): 1424-30.
16. Nielson C, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, et al. (2009) Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev 18 (4): 1077-83.
17. Costa F, da Silva R, Arruda L, Duarte AJ, Casseb J, (2009) Prevalence of human papillomaviruses in urine samples of male patients infected with HIV-1 in Sao Paulo, Brazil. J Med Virol 81 (12): 2007-11.
18. Dickenens P, Srivastava G, Loke SL, Larkin S, (1991) Human papillomavirus 6, 11 and 16 in laryngeal papillomas. J Pathol 165 (3): 243-6.
19. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL, (2011) Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 53 (Suppl 1): S12-21.
20. Schiffman M, Walcholder S, (2012) Success of HPV vaccination is now a matter of coverage. Lancet Oncol 13 (10): 10-2.
21. Manos MM, Ting Y, Wright DK, (1989) The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7: 209-14.
22. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, et al. (2009) Infection of human papilomaviruses in cancers of different human organ sites. Indian J Med Res 130 (3): 222-33.
23. Wong AK, Chan RC, Aggarwal N, Singh MK, Nichols WS, et al. (2010) Human Papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies. Mod Pathol 23 (1): 144-50.
24. Foresta C, Pizzol D, Moretti A, Barzon L, Palù G, et al. (2010) Clinical and prognostic significance of human papillomavirus DNA in the sperm or exfoliated cells of infertile patients and subjects with risk factors. Fertil Steril 94 (5): 1723-7.
25. Deza J, Torrents M, Junquera M, Menendez E, Tamargo A, et al. (2007) Correlación entre genotipos de varones con infección genital por VPH y compañeras sexuales portadoras de neoplasia cervical intraepitelial. XIX Congreso Anual Asociación Española De Patología Cervical y Colposcopia. Oviedo.
26. Benevolo M, Mottolese M, Marandino F, Carosi M, Diodoro MG, et al. (2008) HPV prevalence among healthy Italian male parteners of women with cervical HPV infection. J Med Virol 80: 1275-81.
27. de Lima Rocha MG, Faria FL, Gonςalves L, Souza Mdo C, Fernandes PÁ, et al. (2012) Prevalence of DNA-HPV in male sexual partners of HPV-infected women and concordance of viral types in infected couples. PLoS One 7 (7): e40988.
28. Burchell AN, Tellier PP, Hanley J, Coutlée F, Franco EL, (2010) Human papillomavirus infections among couples in new sexual relationships. Epidemiology 21 (1): 31-7.
29. Partridge JM, Koutsky LA, (2006) Genital human papillomavirus infection in men. Lancet Infect Dis 6: 21-31.
30. Castellsagué X, Ghaffari A, Daniel RW, Bosch FX, Muñoz N, et al. (1997) Prevalence of penile human papillomavirus DNA in husband of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 176: 353-61.
31. Nielson C, Flores R, Harris R, Abrahamsen M, Papenfuss MR, et al. (2007) Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 16: 1107-14.
32. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, et al. (2007) The optimal anatomic sites for sampling heterosexual men for human papillamavirus (HPV) deteccion: the HPV detection in men study. J Infect Dis 196 (8): 1146-52.
33. Flores R, Abalos AT, Nielson CM, Abrahamsen M, Harris RB, et al. (2008) Reliability of sample collection and laboratory testing for HPV detection in men. J Virol Methods 149 (1): 136-43.
34. Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, et al. (2010) Prevalence of human papilomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev 19 (9): 2389-400.
35. Giuliano AR, Lazcano E, Villa LL, Flores R, Salmeron J, et al. (2008) The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brasil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 7: 2036-43.
36. Stone K, Karem K, Sternberg M, McQuillan GM, Poon AD, et al. (2002) Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 186: 1396-02.
37. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV, (2002) The Causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (4): 244-65.
38. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, et al. (1988) The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescentand young women. J Pediatr 132: 277-87.
39. Anderson RM (1999) Transmission dynamics of sexually transmitted infections. Sexually transmitted diseases Holmes K, Matdh P, Sparling P editors. New York: McGraw-Hill. p.25-37.
40. De Oña M, Alvarez-Argüelles ME, Torrents M, Villa L, Rodriguez-Feijoo A, et al. (2010) Prevalence, evolution, and features of infection with human papillomavirus: a 15-year longitudinal study of routine screening of a women population in the north of Spain. J Med Virol 2010;82 (4): 597-604.
41. Armstrong L, Derkay C, Reeves W, (1999) Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg 125: 743-48.
42. Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, et al. (2005) Determinants of prevalence, acquisition, and persistence of human papilomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005;14: 1710-6.
43. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, et al. (2003) Human papilomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003;187: 1064-70.
44. Vaccarella S, Lazcano-Ponce E, Castro-Garduno JA, Cruz-Valdez A, Díaz V, et al. (2006) Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer 119: 1934-9.
45. Centers for Disease Control and Prevention (CDC) (2010) FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal 28, 59 (20): 630-2.
46. Burchell A, Rachel L, de Sanjosé S, Franco E, (2006) Capítulo 6: Epidemiología y dinámica de la transmision de la infección por el VPH. Vaccine 24 (Suppl 3): 54-65.
47. Georgousakis M, Jayasinghe S, Brotherton J, Gilroy N, Chiu C, et al. (2012) Population-wide vaccination against human papilomavirus in adolescent boys: Australia as a case study. Lancet Infect Dis 12 (8): 627-34.